Intravenous magnesium sulfate for acute termination of sustained monomorphic ventricular tachycardia associated with coronary artery disease

Am J Cardiol. 2000 Dec 1;86(11):1270-2, A9. doi: 10.1016/s0002-9149(00)01219-4.

Abstract

The efficacy of intravenous magnesium in terminating sustained monomorphic ventricular tachycardia was examined in this study. This therapy was found to be ineffective in aborting monomorphic ventricular tachycardia induced in the electrophysiology laboratory.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Arrhythmia Agents / administration & dosage*
  • Coronary Disease / complications*
  • Coronary Disease / physiopathology
  • Electrocardiography
  • Female
  • Heart Rate / drug effects
  • Humans
  • Infusions, Intravenous
  • Magnesium Sulfate / administration & dosage*
  • Male
  • Middle Aged
  • Tachycardia, Ventricular / drug therapy*
  • Tachycardia, Ventricular / etiology
  • Tachycardia, Ventricular / physiopathology
  • Treatment Outcome

Substances

  • Anti-Arrhythmia Agents
  • Magnesium Sulfate